Weiss Multi-Strategy Advisers LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$129
-25.0%
119,151
-10.5%
0.00%0.0%
Q2 2023$172
-11.3%
133,179
-9.4%
0.00%
-40.0%
Q1 2023$194
-13.4%
146,929
-1.8%
0.01%
-16.7%
Q4 2022$224
-99.9%
149,606
-23.3%
0.01%0.0%
Q3 2022$230,000
-3.0%
195,000
-7.1%
0.01%
-14.3%
Q2 2022$237,000
-73.4%
210,000
-29.5%
0.01%
-66.7%
Q1 2022$891,000
-11.5%
298,071
-21.6%
0.02%
-8.7%
Q4 2021$1,007,000
-31.7%
380,000
-6.5%
0.02%
-28.1%
Q3 2021$1,475,000
-14.8%
406,205
+1.9%
0.03%
-15.8%
Q2 2021$1,731,000
+31.1%
398,783
+3.3%
0.04%
+31.0%
Q1 2021$1,320,000
-14.6%
386,000
-12.6%
0.03%
-3.3%
Q4 2020$1,546,000
+30.5%
441,760
-10.5%
0.03%
-6.2%
Q3 2020$1,185,000
+29.9%
493,673
-1.0%
0.03%
+23.1%
Q2 2020$912,000
+21.4%
498,539
+3.5%
0.03%
-10.3%
Q1 2020$751,000
-29.8%
481,540
-3.7%
0.03%
+70.6%
Q4 2019$1,070,000
+12.2%
500,000
-2.0%
0.02%
-10.5%
Q3 2019$954,000
-28.3%
510,0000.0%0.02%
-45.7%
Q2 2019$1,331,000
+1.5%
510,0000.0%0.04%
+6.1%
Q1 2019$1,311,000
+11.8%
510,0000.0%0.03%
-32.7%
Q4 2018$1,173,000
-26.2%
510,000
+3.0%
0.05%
+16.7%
Q3 2018$1,589,000
+24.4%
495,000
+9.7%
0.04%
+35.5%
Q2 2018$1,277,000
+33.6%
451,100
+67.1%
0.03%
+3.3%
Q1 2018$956,000
-17.9%
270,000
-10.0%
0.03%0.0%
Q4 2017$1,164,000
+572.8%
300,000
+341.2%
0.03%
+400.0%
Q3 2017$173,000
-7.0%
68,0000.0%0.01%
-25.0%
Q2 2017$186,000
-19.8%
68,000
-2.9%
0.01%
-11.1%
Q1 2017$232,000
+38.9%
70,0000.0%0.01%
+12.5%
Q4 2016$167,000
-39.3%
70,000
-6.7%
0.01%
-52.9%
Q3 2016$275,000
-32.3%
75,000
-58.8%
0.02%
-45.2%
Q2 2016$406,000
-36.0%
182,250
-40.2%
0.03%
+10.7%
Q1 2016$634,000
-31.4%
305,0000.0%0.03%
-56.2%
Q4 2015$924,000
+23.0%
305,000
+0.3%
0.06%
+93.9%
Q3 2015$751,000
-22.0%
304,000
+1.3%
0.03%
-13.2%
Q2 2015$963,000
+17.3%
300,000
+30.4%
0.04%
+5.6%
Q1 2015$821,000
+64.5%
230,000
+4.5%
0.04%
+111.8%
Q4 2014$499,000
+71.5%
220,000
+46.7%
0.02%
+142.9%
Q3 2014$291,000
-46.6%
150,0000.0%0.01%
-41.7%
Q2 2014$545,000
-6.4%
150,0000.0%0.01%0.0%
Q1 2014$582,000
+415.0%
150,000
+278.0%
0.01%
+500.0%
Q4 2013$113,000
-32.3%
39,683
-20.6%
0.00%
-60.0%
Q2 2013$167,00050,0000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders